Corrie M Wortel

Autoreactive B cell responses targeting nuclear antigens in systemic sclerosis: Implications for disease pathogenesis.

J. D. de Vries-Bouwstra, H. Scherer, T. Huizinga, 2022, Seminars in arthritis and rheumatism.

Anti-topoisomerase, but not anti-centromere B cell responses in systemic sclerosis display active, Ig-secreting cells associated with lung fibrosis

J. D. de Vries-Bouwstra, T. Huizinga, R. Toes, 2023, RMD Open.

Cross-reactivity of IgM anti-modified protein antibodies in rheumatoid arthritis despite limited mutational load

J. Drijfhout, T. Huizinga, L. Trouw, 2021, Arthritis Research & Therapy.

Association of Anti–Topoisomerase I Antibodies of the IgM Isotype With Disease Progression in Anti–Topoisomerase I–Positive Systemic Sclerosis

J. D. de Vries-Bouwstra, T. Huizinga, R. Toes, 2020, Arthritis & rheumatology.

Association Between Centromere- and Topoisomerase-specific Immune Responses and the Degree of Microangiopathy in Systemic Sclerosis

J. D. de Vries-Bouwstra, T. Huizinga, R. Toes, 2020, The Journal of Rheumatology.

AB1299 AN ONGOING ANTICENTROMERE ANTIBODY RESPONSE ASSOCIATES WITH PROGRESSION TOWARDS SYSTEMIC SCLEROSIS

T. Huizinga, R. Toes, J. Bakker, 2019, Abstracts Accepted for Publication.